Results 91 to 100 of about 36,764 (181)

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. [PDF]

open access: yesCochrane Database Syst Rev, 2023
Tunnicliffe DJ   +8 more
europepmc   +1 more source

HMG-CoA Reductase Inhibitors Suppress High Glucose-induced Excessive O2⁻ production in J-774 Cells

open access: yes, 2003
Statins (HMG-CoA reductase inhibitors) have so-called pleiotropic effects, which directly reduce neoinitial inflammation of atherosclerosis, and one possible mechanism is the attenuation of oxidative stress.
Kase, Hiroyuki   +4 more
core  

HMG-CoA reductase inhibition preserves testicular function after torsion/detorsion by modulating oxidative stress and AKT signaling. [PDF]

open access: yesSci Rep
Yıldırım B   +8 more
europepmc   +1 more source

Co-existing phaeochromocytoma and anti-HMG-CoA reductase immune-mediated necrotising myositis: a diagnostic challenge. [PDF]

open access: yesEndocrinol Diabetes Metab Case Rep
Maher S   +8 more
europepmc   +1 more source

d-β-Tocotrienol-mediated cell cycle arrest and apoptosis in human melanoma cells

open access: yes, 2010
Background: The rate-limiting enzyme of the mevalonate pathway, 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, provides essential intermediates for the prenylation or dolichylation of growth-related proteins.
Mo, Huanbiao   +2 more
core  

Home - About - Disclaimer - Privacy